Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

Cytokine release syndrome (CRS) represents a life‐threatening side effect after haploidentical stem cell transplantation (Haplo‐SCT) with posttransplant cyclophosphamide (PT‐Cy). Factors predictive of CRS development is still a matter of debate. We retrospectively analyzed 102 consecutive patients r...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancer Med
Κύριοι συγγραφείς: Mariotti, Jacopo, Taurino, Daniela, Marino, Fabrizio, Bramanti, Stefania, Sarina, Barbara, Morabito, Lucio, De Philippis, Chiara, Di Vito, Clara, Mavilio, Domenico, Carlo‐Stella, Carmelo, Della Porta, Matteo, Santoro, Armando, Castagna, Luca
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2019
Θέματα:
Clinical Cancer Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6943086/
https://ncbi.nlm.nih.gov/pubmed/31702882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2607
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια